secwatch.observer — SEC 8-K summary
======================================

Issuer:     Totaligent, Inc. (TGNT)
CIK:        0000846377
Form:       8-K
Filed at:   2026-04-15T23:59:59+00:00
Accession:  0001477932-26-002227
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Totaligent acquires Aetherium Medical ($10M rev); Klarich President, board member
--------------------------------------------------------------------------------

- Totaligent forms subsidiary Aetherium Medical LLC; Klarich contributes trade secrets, know-how, and business network.
- Ivan Klarich appointed President immediately, will join 3-member Board after closing.
- Initial 10% fully-diluted equity (Series D Preferred) issued at closing; additional milestone-based equity.
- Underlying Aetherium platform generated ~$10M annual revenue with >15 years consistent profitability.
- No cash consideration; equity-only. Separate GloMed JV is not a condition of this agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/846377/000147793226002227/0001477932-26-002227-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/846377/000147793226002227/totaligent_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-26-002227

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer